Mitochondrial dysfunction is a key pathogenic factor in obesity-related asthma. Therapies targeting mitochondrial function, oxidative stress, or related pathways may offer new therapeutic approaches. Personalized and multimodal interventions are crucial for improving the treatment of obesity-related asthma.
Jiang et al. (Fri,) studied this question.